| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |